Molecular epidemiology of malaria

Clinical Microbiology Reviews

Volumn 20, Issue 1, 2007, Pages 188-204

  Conway, David J ^a,b  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; AS02A VACCINE; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; MALARIA VACCINE; MEROZOITE SURFACE PROTEIN 1; PYRIMETHAMINE; RNA 18S; SULFADOXINE; UNCLASSIFIED DRUG;

ALLELE; ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; DRUG TREATMENT FAILURE; ENDEMIC DISEASE; EPIDEMIC; GENE SEQUENCE; GENETIC MANIPULATION; GENETIC POLYMORPHISM; GENOME; GENOTYPE; HUMAN; INCIDENCE; LOWEST INCOME GROUP; MALARIA; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PARASITE IDENTIFICATION; PARASITE VIRULENCE; PHYLOGENY; PLASMODIUM FALCIPARUM; POINT MUTATION; PREVALENCE; REVIEW; RNA GENE; SEQUENCE ANALYSIS;

ANIMALS; ANTIGENIC VARIATION; ANTIGENS, PROTOZOAN; ANTIPROTOZOAL AGENTS; DRUG RESISTANCE; EPIDEMIOLOGY, MOLECULAR; HUMANS; MALARIA; PLASMODIUM; POLYMORPHISM, GENETIC; SELECTION (GENETICS); VIRULENCE;

PLASMODIUM FALCIPARUM; RODENTIA;

EID: 33846491759     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.00021-06     Document Type: Review

References (201)

1. Abdel-Muhsin, A. A., M. J. Mackinnon, P. Awadalla, E. Ali, S. Suleiman, S. Ahmed, D. Walliker, and H. A. Babiker. 2003. Local differentiation in Plasmodium falciparum drug resistance genes in Sudan. Parasitology 126:391-400.
2. Alifrangis, M., S. Enosse, R. Pearce, C. Drakeley, C. Roper, I. F. Khalil, W. M. Nkya, A. M. Ronn, T. G. Theander, and I. C. Bygbjerg. 2005. A simple, high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolate reductase, dihydropteroate synthase, and P. falciparum chloroquine resistance transporter genes using polymerase chain reaction- and enzyme-linked immunosorbent assay-based technology. Am. J. Trop. Med. Hyg. 72:155-162.
3. Alloueche, A., P. Milligan, D. J. Conway, M. Pinder, K. A. Bojang, T. Doherty, N. Tornieporth, J. Cohen, and B. M. Greenwood. 2003. Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific. Am. J. Trop. Med. Hyg. 68:97-101.
4. Anderson, T. J. C., B. Haubold, J. T. Williams, J. G. Estrada-Franco, L. Richardson, R. Mollinedo, M. Bockaire, J. Mokili, S. Mharakurwa, N. French, J. Whitworth, I. D. Velez, A. Brockman, F. Nosten, M. U. Ferreira, and K. P. Day. 2000. Microsatellites reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol. Biol. Evol. 17:1467-1482.
5. Anderson, T. J. C., R. E. L. Paul, C. A. Donnelly, and K. P. Day. 2000. Do malaria parasites mate non-randomly in the mosquito midgut? Genet. Res. 75:285-296.
6. Anderson, T. J. C., S. Nair, C. Jacobzone, A. Zavai, and S. Balkan. 2003. Molecular assessment of drug resistance in Plasmodium falciparum from Bahr El Gazal province, Sudan. Trop. Med. Int. Health 8:1068-1073.
7. Anderson, T. J. C. 2004. Mapping drug resistance genes in Plasmodium falciparum by genome-wide association. Curr. Drug Targets Infect. Disord. 4:65-78.
8. Anderson, T. J. C., S. Nair, D. Sudimack, J. T. Williams, M. Mayxay, P. N. Newton, J. P. Guthmann, J. M. Smithuis, T. T. Hien, I. V. van den Broek, N. J. White, and F. Nosten. 2005. Geographical distribution of selected and putatively neutral SNPs in SE asian malaria parasites. Mol. Biol. Evol. 22:2362-2374.
9. Andrews, L., R. F. Andersen, D. Webster, S. Dunachie, R. M. Walther, P. Bejon, A. Hunt-Cooke, G. Bergson, F. Sanderson, A. V. S. Hill, and S. C. Gilbert. 2005. Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials. Am. J. Trop. Med. Hyg. 73:191-198.
10. Anthony, T. G., D. J. Conway, J. Cox-Singh, A. Matusop, S. Ratnam, S. Shamsul, and B. Singh. 2005. Fragmented population structure of Plasmodium falciparum in a region of declining endemicity. J. Infect. Dis. 191:1558-1564.
11. Arez, A. P., G. Snounou, J. Pinto, C. A. Sousa, D. Modiano, H. Ribeiro, A. S. Franco, J. Alves, and V. E. do Rosario. 1999. A clonal Plasmodium falciparum population in an isolated outbreak of malaria in the Republic of Cabo Verde. Parasitology 118:347-355.
12. Ariey, F., D. Hommel, C. Le Scanf, J. B. Duchemin, C. Peneau, A. Hulin, J. L. Sarthou, J. M. Reyes, T. Fandeur, and O. Mercereau-Puijalon. 2001. Association of severe malaria with a specific Plasmodium falciparum genotype in French Guiana. J. Infect. Dis. 184:237-241.
13. Babiker, H. A., L. C. Ranford-Cartwright, D. Currie, J. D. Charlwood, P. Billingsley, T. Teuscher, and D. Walliker. 1994. Random mating in a natural population of the malaria parasite Plasmodium falciparum. Parasitology 109:413-421.
14. Basco, L. K., and P. Ringwald. 1998. Molecular epidemiology of malaria in Yaounde, Cameroon II. Baseline frequency of point mutations in the dihydropteroate synthase gene of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 58:374-377.
15. Basco, L. K., M. Ndounga, M. Tejiokem, V. F. Ngane, J. C. Youmba, P. Ringwald, and G. Soula. 2002. Molecular epidemiology of malaria in Cameroon. XI. Geographic distribution of Plasmodium falciparum isolates with dihydrofolate reductase gene mutations in southern and central Cameroon. Am. J. Trop. Med. Hyg. 67:378-382.
16. Bates, S. J., P. A. Winstanley, W. M. Watkins, A. Alloueche, J. Bwika, T. C. Happi, P. G. Kremsner, J. G. Kublin, Z. Premji, and C. H. Sibley. 2004. Rare, highly pyrimethamine-resistant alleles of the Plasmodium falciparum dihydrofolate reductase gene from 5 African sites. J. Infect. Dis. 190:1783-1792.
17. Baum, J., M. Pinder, and D. J. Conway. 2003. Erythrocyte invasion phenotypes of Plasmodium falciparum in The Gambia. Infect. Immun. 71:1856-1863.
18. Baum, J., A. W. Thomas, and D. J. Conway. 2003. Evidence for diversifying selection on erythrocyte-binding antigens of Plasmodium falciparum and P. vivax. Genetics 163:1327-1336.
19. Beck, H. P., I. Felger, W. Huber, S. Steiger, T. Smith, N. Weiss, P. Alonso, and M. Tanner. 1997. Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of the malaria vaccine SPf66. J. Infect. Dis. 175:921-926.
20. Beck, H. P. 1999. How does molecular epidemiology help to understand malaria? Trop. Med. Int. Health 4:1-3.
21. Beeson, J. G., and G. V. Brown. 2004. Plasmodium falciparum-infected erythiocytes demonstrate dual specificity for adhesion to hyaluronic acid and chondroitin sulfate A and have distinct adhesive properties. J. Infect. Dis. 189:169-179.
22. Bejon, P., L. Andrews, R. F. Andersen, S. Dunachie, D. Webster, M. Walther, S. C. Gilbert, T. Peto, and A. V. S. Hill. 2005. Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites. J. Infect. Dis. 191:619-626.
23. Black, J., M. Hommel, G. Snounou, and M. Pinder. 1994. Mixed infections with Plasmodium falciparum and P. malariae and fever in malaria. Lancet 343:1095.
24. Bozdech, Z., M. Llinas, B. L. Pulliam, E. D. Wong, J. Zhu, and J. L. DeRisi. 2003. The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum. PLoS Biology 1:85-100.
25. Bruce, M. C., C. A. Donnelly, M. P. Alpers, M. R. Galinski, J. W. Barnwell, D. Walliker, and K. P. Day. 2000. Cross-species interactions between malaria parasites in humans. Science 287:845-848.
26. Bruce, M. C., M. R. Galinski, J. W. Barnwell, C. A. Donnelly, M. Walmsley, M. P. Alpers, D. Walliker, and K. P. Day. 2000. Genetic diversity and dynamics of Plasmodium falciparum and P. vivax populations in multiply infected children with asymptomatic malaria infections in Papua New Guinea. Parasitology 121:257-272.
27. Bull, P. C., M. Berriman, S. Kyes, M. A. Quail, N. Hall, M. M. Kortok, K. Marsh, and C. I. Newbold. 2005. Plasmodium falciparum variant surface antigen expression patterns during malaria. PLoS Pathog. 1:e26.
28. Bull, P. C., A. Pain, F. M. Ndungu, S. M. Kinyanjui, D. J. Roberts, C. I. Newbold, and K. Marsh. 2005. Plasmodium falciparum antigenic variation: relationships between in vivo selection, acquired antibody response, and disease severity. J. Infect. Dis. 192:1119-1126.
29. Carlton, J. M., S. V. Angiuoli, B. B. Suh, T. W. Kooy, M. Pertea, J. C. Silva, M. D. Ermolaeva, J. E. Allen, et al. 2002. Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature 419:512-519.
30. Carret, C. K., P. Horrocks, B. Konfortov, E. Winzeler, M. Qureshi, C. Newbold, and A. Ivens. 2005. Microarray-based comparative genomic analyses of the human malaria parasite Plasmodium falciparum using Affymetrix arrays. Mol. Biochem. Parasitol. 144:177-186.
31. Carter, R., and I. A. McGregor. 1973. Enzyme variation in Plasmodium falciparum in The Gambia. Trans. R. Soc. Trop. Med. Hyg. 67:830-837.
32. Cavanagh, D. R., D. Dodoo, L. Hviid, J. A. L. Kurthals, B. D. Akanmori, S. Polley, D. J. Conway, K. Koram, and J. S. McBride. 2004. Antibodies to N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria. Infect. Immun. 72:6492-6502.
33. Checchi, F., R. Durand, S. Balkan, B. T. Vonhm, J. Z. Kollie, P. Biberson, E. Baron, J. Le Bras, and J. P. Guthmann. 2002. High Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine in Harper, Liberia: results in vivo and analysis of point mutations. Trans. R. Soc. Trop. Med. Hyg. 96:664-669.
34. Checchi, F., P. Roddy, S. Kamara, A. Williams, C. Morineau, A. R. Wurie, B. Hora, N. Lamotte, T. Baerwaldt, A. Heinzelmann, A. Danks, L. Pinoges, A. Oloo, R. Durand, L. Ranford-Cartwright, and M. Smet. 2005. Evidence basis for antimalarial policy change in Sierra Leone: five in vivo efficacy studies of chloroquine, sulphadoxine-pyrimethamine and amodiaquine. Trop. Med. Int. Health 10:146-153.
35. Chotivanich, K., R. Udomsangpetch, J. A. Simpson, P. Newton, S. Pukrittayakamee, S. Looareesuwan, and N. J. White. 2000. Parasite multiplication potential and the severity of falciparum malaria. J. Infect. Dis. 181:1206-1209.
36. Chung, J. Y., E. H. Chun, J. H. Chun, and W. G. Kho. 2003. Analysis of the Plasmodium vivax apical membrane antigen-1 gene from re-emerging Korean isolates. Parasitol. Res. 90:325-329.
37. Collins, W. E., and G. M. Jeffery. 2005. Plasmodium ovale: parasite and disease. Clin. Microbiol. Rev. 18:570-581.
38. Conway, D. J., B. M. Greenwood, and J. S. McBride. 1991. The epidemiology of multiple-clone Plasmodium falciparum infections in Gambian patients. Parasitology 103:1-6.
39. Conway, D. J., and J. S. McBride. 1991. Population genetics of Plasmodium falciparum within a malaria hyperendemic area. Parasitology 103:7-16.
40. Conway, D. J., and J. S. McBride. 1991. Genetic evidence for the importance of interrupted feeding by mosquitoes in the transmission of malaria. Trans. R. Soc. Trop. Med. Hyg. 85:454-456.
41. Conway, D. J, 1997. Natural selection on polymorphic malaria antigens and the search for a vaccine. Parasitol. Today 13:26-29.
42. Conway, D. J., C, Roper, A. M. J. Oduola, D. E. Arnot, P. G. Kremsner, M. P. Grobusch, C. F. Curtis, and B. M. Greenwood. 1999. High recombination rate in natural populations of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 96:4506-4511.
43. Conway, D. J., D. R. Cavanagh, K. Tanabe, C. Roper, Z. S. Mikes, N. Sakihama, K. A. Bojang, A. M. J. Oduola, P. G. Kremsner, D. E. Arnot, B. M. Greenwod, and J. S. McBride. 2000. A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat. Med. 6:689-692.
44. Conway, D. J., and S. D. Polley. 2002. Measuring immune selection. Parasitology 125:S3-S16.
45. Cox, S. E., T. Staalsoe, P. Arthur, J. N. Bulmer, L. Hviid, K. Yeboah-Antwi, B. R. Kirkwood, and E. M. Riley. 2005. Rapid acquisition of isolate-specific antibodies to chondroitin sulfate A-adherent Plasmodium falciparum isolates in Ghanaian primigravidae. Infect. Immun. 73:2841-2847.
46. Crabb, B. S. 2002. Transfection technology and the study of drug resistance in the malaria parasite Plasmodium falciparum. Drug Resist. Updat. 5:126-130.
47. Cramer, J. P., F. P. Mockenhaupt, I. Mohl, S. Dittrich, E. Dietz, R. N. Otchwemah, S. Ehrhardt, U. Bienzle, and T. Jelinek. 2004. Allelic dimorphism of the erythrocyte binding antigen-175 (eba-175) gene of Plasmodium falciparum and severe malaria: significant association of the C-segment with fatal outcome in Ghanaian children. Malar. J. 3:11.
48. Daily, J. P., K. G. Le Roch, O. Sarr, X. Fang, Y. Zhou, O. Ndir, S. Mboup, A. Sultan, E. A. Winzeler, and D. F. Wirth. 2004. In vivo transcriptional profiling of Plasmodium falciparum. Malar. J. 3:30.
49. Daily, J. P., K. G. Le Roch, O. Sarr, D. Ndiaye, A. Lukens, Y. Zhou, O. Ndir, S. Mboup, A. Sultan, E. A. Winzeler, and D. F. Wirth. 2005. In vivo transcriptome of Plasmodium falciparum reveals overexpression of transcripts that encode surface proteins. J. Infect. Dis. 191:1196-1203.
50. Deans, A. M., K. E. Lyke, M. A. Thera, C. V. Plowe, A. Kone, O. K. Doumbo, O. Kai, K. Marsh, M. J. Mackinnon, A. Raza, and J. A. Rowe. 2006. Low multiplication rates of African Plasmodium falciparum isolates and lack of association of multiplication rate and red blood cell selectivity with malaria virulence. Am. J. Trop. Med. Hyg. 74:554-563.
51. de Pecoulas, P. E., L. K. Basco, C. M. Wilson, J. Le Bras, and A. Mazabraud. 1996. Molecular characterization of airport malaria. J. Travel Med. 3:179-181.
52. de Roode, J. C., R. Pansini, S. J. Cheesman, M. E. Helinski, S. Huijben, A. R. Wargo, A. S. Bell, B. H. Chan, D. Walliker, and A. F. Read. 2005. Virulence and competitive ability in genetically diverse malaria infections. Proc. Natl. Acad. Sci. USA 102:7624-7628.
53. Diourte, Y., A. Djimde, O. K. Doumbo, I. Sagara, Y. Coulibaly, A. Dicko, M. Diallo, M. Diakite, J. F. Cortese, and C. V. Plowe. 1999. Pyrimethamine-sulfadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali. Am. J. Trop. Med. Hyg. 60:475-478.
54. Djimde, A., O. K. Doumbo, J. F. Cortese, K. Kayentao, S. Doumbo, Y. Diourte, et al. 2001. A molecular marker for chloroquine-resistant falciparum malaria. N. Engl. J. Med. 344:257-263.
55. Djimde, A. A., O. K. Doumbo, O. Traore, A. B. Guindo, K. Kayentao, Y. Diourte, S. Niare-Doumbo, D. Coulibaly, A. K. Kone, Y. Cissoko, M. Tekete, B. Fofana, A. Dicko, D. A. Diallo, T. E. Wellems, D. Kwiatkowski, and C. V. Plowe. 2003. Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 69:558-563.
56. Djimde, A. A., A. Dolo, A. Ouattara, S. Diakite, C. V. Plowe, and O. K. Doumbo. 2004. Molecular diagnosis of resistance to antimalarial drugs during epidemics and in war zones. J. Infect. Dis. 190:853-855.
57. Dokomajilar, C., Z. M. Lankoande, G. Dorsey, I. Zongo, J. B. Ouedraogo, and P. J. Rosenthal. 2006. Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine- pyrimethamine in Burkina Faso. Am. J. Trop. Med. Hyg. 75:162-165.
58. Dondorp, A. M., V. Desakorn, W. Pongtavornpinyo, D. Sahassananda, K. Silamut, K. Chotivanich, P. N. Newton, P. Pitisuttithum, A. M. Smithyman, N. J. White, and N. P. Day. 2005. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med. 2:e204.
59. Dorsey, G., A. F. Gasasira, R. Machekano, M. R. Kamya, S. G. Staedke, and A. Hubbard. 2004. The impact of age, temperature, and parasite density on treatment outcomes from antimalarial clinical trials in Kampala, Uganda. Am. J. Trop. Med. Hyg. 71:531-536.
60. Duffy, M. F., T. J. Byrne, S. R. Elliott, D. W. Wilson, S. J. Rogerson, J. G. Beeson, R. Noviyanti, and G. V. Brown. 2005. Broad analysis reveals a consistent pattern of var gene transcription in Plasmodium falciparum repeatedly selected for a defined adhesion phenotype. Mol. Microbiol. 56:774-788.
61. Duffy, M. F., A. Caragounis, R. Noviyanti, H. M. Kyriacou, E. K. Choong, K. Boysen, J. Healer, J. A. Rowe, M. E. Molyneux, G. V. Brown, and S. J. Rogerson. 2006. Transcribed var genes associated with placental malaria in Malawian women. Infect. Immun. 74:4875-4883.
62. Dunyo, S., R. Ord, R. Hallett, M. Jawara, G. Walraven, E. Mesa, R. Coleman, M. Sowe, N. Alexander, G. A. Targett, M. Pinder, and C. J. Sutherland. 2006. Randomised trial of chloroquine/sulphadoxine-pyrimethamine in Gambian children with malaria: impact against multidrug-resistant P. falciparum. PLoS Clin. Trials 1:e14.
63. Duraisingh, M. T., J. Curtis, and D. C. Warhurst. 1998. Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Exp. Parasitol. 89:1-8.
64. Duraisingh, M. T., A. G. Maier, T. Triglia, and A. F. Cowman. 2003. Erythrocyte-binding antigen 175 mediates invasion in Plasmodium falciparum utilizing sialic acid-dependent and -independent pathways. Proc. Natl. Acad. Sci. USA 100:4796-4801.
65. Duraisingh, M. T., T. Triglia, S. A. Ralph, J. C. Rayner, J. W. Barnwell, G. I. McFadden, and A. F. Cowman. 2003. Phenotypic variation of Plasmodium falciparum merozoite proteins directs receptor targeting for invasion of human erythrocytes. EMBO J. 22:1047-1057.
66. Dye, C., and B. G. Williams. 1997. Multigenic drug resistance among inbred malaria parasites. Proc. R. Soc. Lond. Ser. B 264:61-67.
67. Eberl, K. J., T. Jelinek, A. O. Aida, G. Peyerl-Hoffmann, C. Heuschkel, A. O. el Valy, and E. M. Christophel. 2001. Prevalence of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from southern Mauritania. Trop. Med. Int. Health 6:756-760.
68. Engelbrecht, F., I. Felger, B. Genton, M. Alpers, and H.-P. Beck. 1995. Plasmodium falciparum: malaria morbidity is associated with specific merozoite surface antigen 2 genotypes. Exp. Parasitol. 81:90-96.
69. Enosse, S., C. Dobano, D. Quelhas, J. J. Aponte, M. Lievens, A. Leach, J. Sacarlal, B. M. Greenwood, J. Milman, F. Dubovsky, J. Cohen, R. Thompson, W. R. Ballou, P. L. Alonso, D. J. Conway, and C. J. Sutherland. 2006. RTS,S/ ASO2 malaria vaccine does not induce selection of parasites encoding divergent CSP T-cell epitopes and reduces the genotypic multiplicity of Plasmodium falciparum infections. PLOS Clin. Trials 1:e5.
70. Escalante, A. A., O. E. Cornejo, D. E. Freeland, A. C. Poe, E. Durrego, W. E. Collins, and A. A. Lal. 2005. A monkey's tale: the origin of Plasmodium vivax as a human malaria parasite. Proc. Natl. Acad. Sci. USA 102:1980-1985.
71. Fairhurst, R. M., D. I. Baruch, N. J. Brittain, G. R. Ostera, J. S. Wallach, H. L. Hoang, K. Hayton, A. Guindo, M. O. Makobongo, O. M. Schwartz, A. Tounkara, O. K. Doumbo, D. A. Diallo, H. Fujioka, M. Ho, and T. E. Wellems. 2005. Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria. Nature 435:1117-1121.
72. Fandeur, T., B. Volney, C. Peneau, and B. De Thoisy. 2000. Monkeys of the rainforest in French Guiana are natural reservoirs for P. brasilianum/P. malariae malaria. Parasitology 120:11-21.
73. Farcas, G. A., R. Sceller, K. Zhong, A. Zahirieh, and K. C. Kain. 2006. Real-time polymerase chain reaction assay for the rapid detection and characterization of chloroquine-resistant Plasmodium falciparum malaria in returned travelers. Clin. Infect. Dis. 42:622-627.
74. Farnert, A., G. Snounou, I. Rooth, and A. Bjorkman. 1997. Daily dynamics of Plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area. Am. J. Trop. Med. Hyg. 56:538-547.
75. Farnert, A., A. P. Arez, H. A. Babiker, H. P. Beck, A. Benito, A. Bjorkman, M. C. Bruce, D. J. Conway, K. P. Day, L. Henning, O. Mercereau-Puijalon, L. C. Ranford-Cartwright, J. M. Rubio, G. Snounou, D. Walliker, J. Zwetyenga, and V. E. do Rosario. 2001. Genotyping of Plasmodium falciparum infections by PCR: a comparative multicentre study. Trans. R. Soc. Trop. Med. Hyg. 95:225-232.
76. Farnert, A., and A. Bjorkman. 2005. Limited advantage of multiple consecutive samples for genotyping Plasmodium falciparum populations during the first days of treatment. Am. J. Trop. Med. Hyg. 73:204-206.
77. Feng, X., J. M. Carlton, D. A. Joy, J. Mu, T. Furuya, B. B. Suh, Y. Wang, J. W. Barnwell, and X. Z. Su. 2003. Single-nucleotide polymorphisms and genome diversity in Plasmodium vivax. Proc. Natl. Acad. Sci. USA 100:8502-8507.
78. Fidock, D. A., T. Nomura, A. K. Talley, R. A. Cooper, S. M. Dzekunov, M. T. Ferdig, et al. 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 6:861-871.
79. Fivelman, Q. L., G. A. Butcher, I. S. Adagu, D. C. Warhurst, and G. Pasvol. 2002. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria. Malar. J. 1:1.
80. Francis, D., S. L. Nsobya, A. Talisuna, A. Yeka, M. R. Kamya, R. Machekano, C. Dokomajilar, P. J. Rosenthal, and G. Dorsey. 2006. Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance. J. Infect. Dis. 193:978-986.
81. Gandon, S., M. J. Mackinnon, B. H. K. Chan, and A. F. Read. 2001. Imperfect vaccines and the evolution of parasite virulence. Nature 414:751-755.
82. Gardner, M. J., N. Hall, E. Fung, O. White, M. Berriman, R. W. Hyman, J. M. Carlton, and A. Pain. 2002. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419:498-511.
83. Gaur, D., T. Furuya, J. Mu, L. B. Jiang, X. Z. Su, and L. H. Miller. 2006. Upregulation of expression of the reticulocyte homology gene 4 in the Plasmodium falciparum clone Dd2 is associated with a switch in the erythrocyte invasion pathway. Mol. Biochem. Parasitol. 145:205-215.
84. Genton, B., I. Betuela, I. Felger, F. Al-Yaman, R. F. Anders, A. Saul, L. Rare, M. Baisor, K. Lorry, G. V. Brown, D. Pye, D. O. Irving, T. A. Smith, H. P. Beck, and M. P. Alpers. 2002. A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. J. Infect. Dis. 185:820-827.
85. Gilberger, T.-M., J. K. Thompson, T. Triglia, R. T. Good, M. T. Duraisingh, and A. F. Cowman. 2003. A novel erythrocyte binding antigen-175 paralogue from Plasmodium falciparum defines a new trypsin-resistant receptor on human erythrocytes. J. Biol. Chem. 278:14480-14486.
86. Greenwood, B. 2002. The molecular epidemiology of malaria. Trop. Med. Int. Health 7:1012-1021.
87. Hall, N., M. Karras, J. D. Raine, J. M. Carlton, T. W. Kooij, M. Berriman, L. Florens, C. S. Janssen, A. Pain, G. K. Christophides, K. James, K. Rutherford, B. Harris, D. Harris, C. Churcher, M. A. Quail, D. Ormorid, J. Doggett, H. E. Trueman, J. Mendoza, S. L. Bidwell, M. A. Rajandream, D. J. Carucci, J. R. Yates III, F. C. Kafatos, C. J. Janse, B. Barrell, C. M. Turner, A. P. Waters, and R. E. Sinden. 2005. A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. Science 307:82-86.
88. Hanna, J. N., S. A. Ritchie, D. P. Eisen, R. D. Cooper, D. L. Brookes, and B. L. Montgomery. 2004. An outbreak of Plasmodium vivax malaria in Far North Queensland, 2002. Med. J. Aust. 180:24-28.
89. Happi, C. T., G. O. Gbotosho, O. A. Folarin, D. O. Akinboye, B. O. Yusuf, O. O. Ebong, A. Sowunmi, D. E. Kyle, W. Milhous, D. F. Wirth, and A. M. Oduola. 2005. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria. Acta Trop. 95:183-193.
90. Hartl, D. L. 2004. The origin of malaria: mixed messages from genetic diversity. Nat. Rev. Microbiol. 2:15-22.
91. Haywood, M., D. J. Conway, H. Weiss, W. Metzger, U. D'Alessandro, G. Snounou, G. Targett, and B. Greenwood. 1999. Reduction in the mean number of Plasmodium falciparum genotypes in Gambian children immunized with the malaria vaccine SPf66. Trans. R. Soc. Trop. Med. Hyg. 93:(Suppl. 1)65-68.
92. Horrocks, P., R. Pinches, Z. Christodoulou, S. A. Kyes, and C. I. Newbold. 2004. Variable var transition rates underlie antigenic variation in malaria. Proc. Natl. Acad. Sci. USA 101:11129-11134.
93. Hviid, L. 2004. The immuno-epidemiology of pregnancy-associated Plasmodium falciparum malaria: a variant surface antigen-specific perspective. Parasite Immunol. 26:477-486.
94. Imwong, M., D. Sudimack, S. Pukrittayakamee, L. Osorio, J. M. Carlton, N, P. Day, N. J. White, and T. J. C. Anderson. 2006. Microsatellite variation, repeat array length, and population history of Plasmodium vivax. Mol. Biol. Evol. 23:1016-1018.
95. Jafari, S., R. Durand, D. Lusina, and J. Le Bras. 2002. Molecular characterisation of airport malaria: four cases in France during summer 1999. Parasite 9:187-191.
96. Jensen, A. T. R., P. Magistrado, S. Sharp, L. Joergensen, T. Lavstsen, A. Chiucchiuini, A. Salanti, L. S. Vestergaard, et al. 2004. Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes. J. Exp. Med. 199:1179-1190.
97. Jongwutiwes, S., C. Putaporntip, T. Iwasaki, T. Sata, and H. Kanbara. 2004. Naturally acquired Plasmodium knowlesi malaria in human, Thailand. Emerg. Infect. Dis. 10:2211-2213.
98. Jongwutiwes, S., C. Putaporntip, T. Iwasaki, M. U. Ferreira, H. Kanbara, and A. L. Hughes. 2005. Mitochondrial genome sequences support ancient population expansion in Plasmodium vivax. Mol. Biol. Evol. 22:1733-1739.
99. Joy, D. A., X. Feng, J. Mu, T. Furuya, K. Chotivanich, A. U. Krettli, M. Ho, A. Wang, N. J. White, E. Suh, P. Beerli, and X.-Z. Su. 2003. Early origin and recent expansion of Plasmodium falciparum. Science 300:318-321.
100. Kaestli, M., I. A. Cockburn, A. Cortes, K. Baea, J. A. Rowe, and H. P. Beck. 2006. Virulence of malaria is associated with differential expression of Plasmodium falciparum var gene subgroups in a case-control study. J. Infect. Dis. 193:1567-1574.
101. Khalil, I. F., M. Alifrangis, D. S. Tarimo, T. Staalso, G. M. Satti, T. G. Theander, A. M. Ronn, and I. C. Bygbjerg. 2005. The roles of the pfcrt 76T and pfmdr1 86Y mutations, immunity and the initial level of parasitaemia, in predicting the outcome of chloroquine treatment in two areas with different transmission intensities. Ann. Trop. Med. Parasitol. 99:441-448.
102. Kissinger, J. C., W. E. Collins, J. Li, and T. F. McCutchan. 1998. Plasmodium inui is not closely related to other quartan Plasmodium species. J. Parasitol. 84:278-282.
103. Knowles, R., and B. M. Das Gupta. 1932. A study of monkey malaria and its experimental transmission to man. Ind. Med. Gaz. 67:301-320.
104. Kocken, C. H., H. Ozwara, A. van der Wel, A. L. Beetsma, J. M. Mwenda, and A. W. Thomas. 2002. Plasmodium knowlesi provides a rapid in vitro and in vivo transfection system that enables double-crossover gene knockout studies. Infect. Immun. 70:655-660.
105. Kofoed, P. E., M. Alifrangis, A. Poulsen, A. Rodrigues, S. B. Gjedde, A. Ronn, and L. Rombo. 2004. Genetic markers of resistance to pyrimethamine and sulfonamides in Plasmodium falciparum parasites compared with the resistance patterns in isolates of Escherichia coli from the same children in Guinea-Bissau. Trop. Med. Int. Health 9:171-177.
106. Kooij, T. W., J. M. Carlton, S. L. Bidwell, N. Hall, J. Ramesar, C. J. Janse, and A. P. Waters. 2005. A Plasmodium whole-genome synteny map: indels and synteny breakpoints as foci for species-specific genes. PLoS Pathog. 1:e44.
107. Kublin, J. G., F. K. Dzinjalamala, D. D. Kamwendo, E. M. Malkin, J. F. Cortese, L. M. Martino, R. A. Mukadam, S. J. Rogerson, A. G. Lescano, M. E. Molyneux, P. A. Winstanley, P. Chimpeni, T. E. Taylor, and C. V. Plowe. 2002. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J. Infect. Dis. 185:380-388.
108. Kuhn, S., M. J. Gill, and K. C. Kain. 2005. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa. Am. J. Trop. Med. Hyg. 72:407-409.
109. Kun, J. F., R. J. Schmidt-Ott, L. G. Lehman, B. Lell, D. Luckner, B. Greve, P. Matousek, and P. G. Kremsner. 1998. Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambarene, Gabon. Trans. R. Soc. Trop. Med. Hyg. 92:110-114.
110. Kwiatkowski, D. P. 2005. How malaria has affected the human genome and what human genetics can teach us about malaria. Am. J. Hum. Genet. 77:171-192.
111. Kyes, S., R. Harding, G. Black, A. Craig, N. Peshu, C. Newbold, and K. Marsh. 1997. Limited spatial clustering of individual Plasmodium falciparum alleles in field isolates from coastal Kenya. Am. J. Trop. Med. Hyg. 57:205-215.
112. Lavstsen, T., A. Salanti, A. T. R. Jensen, D. E. Arnot, and T. G. Theander. 2003. Sub-grouping of Plasmodium falciparum 3D7 var genes based on sequence analysis of coding and non-coding regions. Malar. J. 2:27.
113. Lee, E. A., K. L. Flanagan, G. Minigo, W. H. Reece, R. Bailey, M. Pinder, A. V. Hill, and M. Plebanski. 2006. Dimorphic Plasmodium falciparum merozoite surface protein-1 epitopes turn off memory T cells and interfere with T cell priming. Eur. J. Immunol. 36:1168-1178.
114. Lee, S. A., A. Yeka, S. L. Nsobya, C. Dokomajilar, P. J. Rosenthal, A. Talisuna, and G. Dorsey. 2006. Complexity of Plasmodium falciparum infections and antimalarial drug efficacy at 7 sites in Uganda. J. Infect. Dis. 193:1160-1163.
115. Le Roch, K. G., Y. Zhou, P. L. Blair, M. Grainger, J. K. Moch, J. D. Haynes, P. De la Vega, A. A. Holder, S. Batalov, D. J. Carucci, and E. A. Winzeler. 2003. Discovery of gene function by expression profiling of the malaria parasite life cycle. Science 301:1503-1508.
116. Lobo, C. A., K. de Frazao, M. Rodriguez, M. Reid, M. Zalis, and S. Lustigman. 2004. Invasion profiles of Brazilian field isolates of Plasmodium falciparum: phenotypic and genotypic analyses. Infect. Immun. 72:5886-5891.
117. Lum, J. K., A. Kaneko, K. Tanabe, N. Takahashi, A. Bjorkman, and T. Kobayakawa. 2004. Malaria dispersal among islands: human mediated Plasmodium falciparum gene flow in Vanuatu, Melanesia. Acta Trop. 90:181-185.
118. Machado, R. L., M. M. Povoa, V. S. P. Calvosa, M. U. Ferreira, A. R. B. Rossit, E. J. M. dos Santos, and D. J. Conway. 2004. Genetic structure of Plasmodium falciparum populations in the Brazilian Amazon region. J. Infect. Dis. 190:1547-1555.
119. Maier, A. G., M. T. Duraisingh, J. C. Reeder, S. S. Patel, J. W. Kazura, P. A. Zimmerman, and A. F. Cowman. 2003. Plasmodium falciparum erythrocyte invasion through glycophorin C and selection for Gerbich negativity in human populations. Nat. Med. 9:87-92.
120. Maitland, K., T. N. Williams, S. Bennett, C. I. Newbold, T. E. Peto, J. Viji, R. Timothy, J. B. Clegg, D. J. Weatherall, and D. K. Bowden. 1996. The interaction between Plasmodium falciparum and P. vivax in children on Espiritu Santo island, Vanuatu. Trans. R. Soc. Trop. Med. Hyg. 90:614-620.
121. Mangold, K. A., R. U. Manson, E. S. Koay, L. Stephens, M. Regner, R. B. Thomson, Jr., L. R. Peterson, and K. L. Kaul. 2005. Real-time PCR for detection and identification of Plasmodium spp. J. Clin. Microbiol. 43:2435-2440.
122. Mayxay, M., S. Pukrittayakamee, K. Chotivanich, S. Looareesuwan, and N. J. White. 2001. Persistence of Plasmodium falciparum HRP-2 in successfully treated acute falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 95:179-182.
123. McBride, J. S., D. Walliker, and G. Morgan. 1982. Antigenic diversity in the human malaria parasite Plasmodium falciparum. Science 217:254-257.
124. McCollum, A. M., A. C. Poe, M. Hamel, C. Huber, Z. Zhon, Y. P. Shi, P. Ouma, J. Vulule, P. Bloland, L. Slutsker, J. W. Barnwell, V. Udhayakumar, and A. A. Escalante. 2006. Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. J. Infect. Dis. 194:189-197.
125. Mehlotra, R. K., L. J. Kasehagen, M. Baisor, K. Lorry, J. W. Kazura, M. J. Bockarie, and P. A. Zimmerman. 2002. Malaria infections are randomly distributed in diverse holoendemic areas of Papua New Guinea. Am. J. Trop. Med. Hyg. 67:555-562.
126. Metzger, W. G., D. M. N. Okenu, D. R. Cavanagh, J. V. Robinson, K. A. Bojang, H. A. Weiss, J. S. McBride, B. M. Greenwood, and D. J. Conway. 2003. Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria. Parasite Immunol. 25:307-312.
127. Mockenhaupt, F. P., S. Ehrhardt, T. A. Eggelte, P. Agana-Nsiire, K. Stollberg, A. Mathieu, M. Markert, R. N. Otchwemah, and U. Bienzle. 2005. Chloroquine-treatment failure in northern Ghana: roles of pfcrt T76 and pfmdr1 Y86. Ann. Trop. Med. Parasitol. 99:723-732.
128. Mockenhaupt, F. P., J. Teun Bousema, T. A. Eggelte, J. Schreiber, S. Ehrhardt, N. Wassilew, R. N. Otchwemah, R. W. Sauerwein, and U. Bienzle. 2005. Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana. Trop. Med. Int Health 10:901-908.
129. Montgomery, J., D. A. Milner, Jr., M. T. Tse, A. Njobvu, K. Kayira, C. P. Dzamalala, T. E. Taylor, S. J. Rogerson, A. G. Craig, and M. E. Molyneux. 2006. Genetic analysis of circulating and sequestered populations of Plasmodium falciparum in fatal pediatric malaria. J. Infect. Dis. 194:115-122.
130. Mu, J., J. Duan, K. D. Makova, D. A. Joy, C. Q. Huynh, O. H. Branch, W.-H. Li, and X.-Z. Su. 2002. Chromosome-wide SNPs reveal an ancient origin for Plasmodium falciparum. Nature 418:323-326.
131. Mu, J., P. Awadalla, J. Duan, K. M. McGee, D. A. Joy, G. A. McVean, and X.-Z. Su. 2005. Recombination hotspots and population structure in Plasmodium falciparum. PLOS Biology 3:1734-1741.
132. Mu, J., D. A. Joy, J. Duan, Y. Huang, J. Carlton, J. Walker, J. Barnwell, P. Beerli, M. A. Charleston, O. G. Pybus, and X. Z. Su. 2005. Host switch leads to emergence of Plasmodium vivax malaria in humans. Mol. Biol. Evol. 22:1686-1693.
133. Musset, L., B. Pradines, D. Parzy, R. Durand, P. Bigot, and J. Le Bras. 2006. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers. J. Antimicrob. Chemother. 57:110-115.
134. Mutabingwa, T. K., D. Anthony, A. Heller, R. Hallett, J. Ahmed, C. Drakeley, B. M. Greenwood, and C. J. Whitty. 2005. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet 365:1474- 1480.
135. Nair, S., J. T. Williams, A. Brockman, L. Paiphum, M. Mayxay, P. N. Newton, J.-P. Guthmann, F. M. Smithuis, T. T. Hien, N. J. White, F. Nosten, and T. J. C. Anderson. 2003. A selective sweep driven by pyrimethamine treatment in southeast Asian malaria parasites. Mol. Biol. Evol. 20:1526-1536.
136. Nash, D., S. Nair, M. Mayxay, P. N. Newton, J. P. Guthmann, F. Nosten, and T. J. C. Anderson. 2005. Selection strength and hitchhiking around two anti-malarial resistance genes. Proc. Biol. Sci. 272:1153-1161.
137. Ndiaye, D., J. P. Daily, O. Sarr, O. Ndir, O. Gaye, S. Mboup, and D. F. Wirth. 2005. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Senegal. Trop. Med. Int. Health 10:1176-1179.
138. Nery, S., A.-M. Deans, M. Mosobo, K. Marsh, J. A. Rowe, and D. J. Conway. 2006. Expression of Plasmodium falciparum genes involved in erythrocyte invasion varies among isolates cultured directly from patients. Mol. Biochem. Parasitol. 149:208-215.
139. Niare, O., K. Markianos, J. Volz, F. Oduol, A. Toure, M. Bagayoko, D. Sangare, S. F. Traore, R. Wang, C. Blass, G. Dolo, M. Bouare, F. C. Kafatos, L. Kruglyak, Y. T. Toure, and K. D. Vernick. 2002. Genetic loci affecting resistance to human malaria parasites in a West African mosquito vector population. Science 298:213-216.
140. Nielsen, M. A., T. Staalsoe, J. A. L. Kurtzhals, B. Q. Goka, D. Dodoo, M. Alifrangis, T. G. Theander, B. D. Akanmori, and L. Hviid. 2002. Plasmodium falciparum variant surface antigen expression varies between isolates causing severe and nonsevere malaria and is modified by host immunity. J. Immunol. 168:3444-3450.
141. Ochola, L. B., K. Marsh, B. Lowe, S. Gal, G. Pluschke, and T. Smith. 2005. Estimation of the sequestered parasite load in severe malaria patients using both host and parasite markers. Parasitology 131:449-458.
142. Okoyeh, J. N., C. R. Pillai, and C. E. Chitnis. 1999. Plasmodium falciparum field isolates commonly use erythrocyte invasion pathways that are independent of sialic acid residues of glycophorin A. Infect. Immun. 67:5784-5791.
143. Paganotti, G. M., H. A. Babiker, D. Modiano, B. S. Sirima, F. Verra, A. Konate, A. L. Ouedraogo, A. Diarra, M. J. Mackinnon, M. Coluzzi, and D. Walliker. 2004. Genetic complexity of Plasmodium falciparum in two ethnic groups of Burkina Faso with marked differences in susceptibility to malaria. Am. J. Trop. Med. Hyg. 71:173-178.
144. Paget-McNicol, S., and A. Saul. 2001. Mutation rates in the dihydrofolate reductase gene of Plasmodium falciparum. Parasitology 122:497-505.
145. Paul, R. E. L., M. J. Packer, M. Walmsley, M. Lagog, L. C. Ranford-Cartwright, R. Paru, and K. P. Day. 1995. Mating patterns in malaria parasite populations of Papua New Guinea. Science 269:1709-1711.
146. Pearce, R., A. Malisa, S. P. Kachur, K. Barnes, B. Sharp, and C. Roper. 2005. Reduced variation around drug-resistant dhfr alleles in African Plasmodium falciparum. Mol. Biol. Evol. 22:1834-1844.
147. Pearce, R. J., C. Drakeley, D. Chandramohan, F. Mosha, and C. Roper. 2003. Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrob. Agents Chemother. 47:1347-1354.
148. Pinder, M., C. J. Sutherland, F. Sisay-Joof, J. Ismaili, M. B. B. McCall, R. Ord, R. Hallett, A. A. Holder, and P. Milligan. 2006. IgG antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children. Infect. Immun. 74:2887-2893.
149. Polley, S. D., and D. J. Conway. 2001. Strong diversifying selection on domains of the Plasmodium falciparum apical membrane antigen 1 gene. Genetics 158:1505-1512.
150. Polley, S. D., W. Chokejindachai, and D. J. Conway. 2003. Allele frequency based analyses robustly identify sites under balancing selection in a malaria vaccine candidate antigen. Genetics 165:555-561.
151. Polley, S. D., T. Mwangi, C. H. Kocken, A. W. Thomas, S. Dutta, D. E. Lanar, E. Remarque, A. Ross, T. N. Williams, G. Mwambingu, B. Lowe, D. J. Conway, and K. Marsh. 2004. Human antibodies to recombinant protein constructs of Plasmodium falciparum apical membrane antigen 1 (AMA1) and their associations with protection from malaria. Vaccine 23:718-728.
152. Policy, S. D., D. J. Conway, D. R. Cavanagh, J. S. McBride, B. Lowe, T. N. Williams, T. Mwangi, and K. Marsh. 2006. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Vaccine 24:4233-4246.
153. Policy, S. D., K. K. A. Tetteh, J. M. Lloyd, O. J. Akpogheneta, B. M. Greenwood, K. A. Bojang, and D. J. Conway. 2007. Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection. J. Infect. Dis. 195:279-287.
154. Price, R. N., A. C. Uhlemann, A. Brockman, R. McGready, E. Ashley, L. Phaipun, R. Patel, K. Laing, S. Looareesuwan, N. J. White, F. Nosten, and S. Krishna. 2004. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364:438-447.
155. Price, R. N., A. C. Uhlemann, M. van Vugt, A. Brockman, R. Hutagalung, S. Nair, D. Nash, P. Singhasivanon, T. J. Anderson, S. Krishna, N. J. White, and F. Nosten. 2006. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin. Infect. Dis. 42:1570-1577.
156. Rathod, P. K., T. McErlean, and P. C. Lee. 1997. Variations in frequencies of drug resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 94:9389-9393.
157. Razakandrainibe, F. G., P. Durand, J. C. Koella, T. De Meeus, F. Roussel, F. J. Ayala, and F. Renaud. 2005. "Clonal" population structure of the malaria agent Plasmodium falciparum in high-infection regions. Proc. Natl. Acad. Sci. USA 102:17388-17393.
158. Read, A. F., and L. H. Taylor. 2001. The ecology of genetically diverse infections. Science 292:1099-1102.
159. Read, A. F., M. J. Mackinnon, A. Anwar, and L. H. Taylor. 2002. Kin-selection models as evolutionary explanations of malaria, p. 165-178. In U. Dieckmann et al. (ed.), Adaptive dynamics of infectious disease: in pursuit of virulence management. Cambridge University Press, Cambridge, United Kingdom.
160. Recker, M., S. Nee, P. C. Bull, S. Kinyanjui, K. Marsh, C. Newbold, and S. Gupta. 2004. Transient cross-reactive immune responses can orchestrate antigenic variation in malaria. Nature 429:555-558.
161. Robert, F., F. Ntoumi, G. Angel, D. Candito, C. Regier, T. Fandeur, J. L. Sarthou, and O. Mercereau-Puyalon. 1996. Extensive genetic diversity of Plasmodium falciparum isolates collected from patients with severe malaria in Dakar, Senegal. Trans. R. Soc. Trop. Med. Hyg. 90:704-711.
162. Roper, C., I. M. Elhassan, L. Hviid, H. Giha, W. Richardson, H. Babiker, G. M. H. Satti, T. G. Theander, and D. E. Arnot. 1996. Detection of very low level Plasmodium falciparum infections using the nested polymerase chain reaction and a reassessment of the epidemiology of unstable malaria in Sudan. Am. J. Trop. Med. Hyg. 54:325-331.
163. Roper, C., W. Richardson, I. M. Elhassan, H. Giha, L. Hviid, G. M. H. Satti, T. G. Theander, and D. E. Arnot. 1998. Seasonal changes in the Plasmodium falciparum population in individuals and their relationship to clinical malaria: a longitudinal study in a Sudanese village. Parasitology 116:501-510.
164. Roper, C., R. Pearce, B. Bredenkamp, J. Gumede, C. Drakeley, F. Mosha, D. Chandramohan, and B. Sharp. 2003. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet 361:1174-1181.
165. Roper, C., R. Pearce, S. Nair, B. Sharp, F. Nosten, and T. Anderson. 2004. Intercontinental spread of pyrimethamine resistant malaria. Science 305:1124.
166. Rottmann, M., T. Lavstsen, J. P. Mugasa, M. Kaestli, A. T. Jensen, D. Muller, T. Theander, and H. P. Beck. 2006. Differential expression of var gene groups is associated with morbidity caused by Plasmodium falciparum infection in Tanzanian children. Infect. Immun. 74:3904-3911.
167. Rougemont, M., M. Van Saanen, R. Sahli, H. P. Hinrikson, J. Bille, and K. Jaton. 2004. Detection of four Plasmodium species in blood from humans by 18S rRNA gene subunit-based and species-specific real-time PCR assays. J. Clin. Microbiol. 42:5636-5643.
168. Rowe, J. A., and S. A. Kyes. 2004. The role of Plasmodium falciparum var genes in malaria in pregnancy. Mol. Microbiol. 53:1011-1019.
169. Sakihama, N., H. Ohmae, B. Bakote'e, M. Kawabata, K. Hirayama, and K. Tanabe. 2006. Limited allelic diversity of Plasmodium falciparum merozoite surface protein 1 gene from populations in the Solomon Islands. Am. J. Trop. Med. Hyg. 74:31-40.
170. Salanti, A., M. Dahlback, L. Turner, M. A. Nielsen, L. Barfod, P. Magistrado, A. T. Jensen, T. Lavstsen, M. F. Ofori, K. Marsh, L. Hviid, and T. G. Theander. 2004. Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J. Exp. Med. 200:1197-1203.
171. Sibley, C. H., and P. Ringwald. 2006. A database of antimalarial drug resistance. Malar. J. 5:48.
172. Silamut, K., and N. J. White. 1993. Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 87:436-443.
173. Simpson, J. A., L. Aarons, W. E. Collins, G. M. Jeffery, and N. J. White. 2002. Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infection. Parasitology 124:247-263.
174. Singh, B., A. Bobogare, J. Cox-Singh, G. Snounou, M. S. Abdullah, and H. A. Rahman. 1999. A genus- and species-specific nested polymerase chain reaction malaria detection assay for epidemiological studies. Am. J. Trop. Med. Hyg. 60:687-692.
175. Singh, B., L. Kim Sung, A. Matusop, A. Radhakrishnan, S. S. Shamsul, J. Cox-Singh, A. Thomas, and D. J. Conway. 2004. A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet 363:1017-1024.
176. Slater, M., M. Kiggundu, C. Dokomajilar, M. R. Kamya, N. Bakyaita, A. Talisuna, P. J. Rosenthal, and G. Dorsey. 2005. Distinguishing recrudescences from new infections in antimalarial clinical trials: major impact of interpretation of genotyping results on estimates of drug efficacy. Am. J. Trop. Med. Hyg. 73:256-262.
177. Snounou, G., S. Viriyakosol, X. P. Zhu, W. Jarra, L. Pinheiro, V. E. do Rosario, S. Thaithong, and K. N. Brown. 1993. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol. Biochem. Parasitol. 61:315-320.
178. Snounou, G., X. Zhu, N. Siripoon, W. Jarra, S. Thaithong, K. N. Brown, and S. Viriyakosol. 1999. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Trans. R. Soc. Trop. Med. Hyg. 93:369-374.
179. Staalsoe, T., C. E. Shulman, J. N. Bulmer, K. Kawuondo, K. Marsh, and L. Hviid. 2004. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet 363:283-289.
180. Stubbs, J., K. M. Simpson, T. Triglia, D. Plouffe, C. J. Tonkin, M. T. Duraisingh, A. G. Maier, E. A. Winzeler, and A. F. Cowman. 2005. Molecular mechanism for switching of P. falciparum invasion pathways into human erythrocytes. Science 309:1384-1387.
181. Stump, A. D., M. C. Fitzpatrick, N. F. Lobo, S. Traore, N. Sagnon, C. Costantini, F. H. Collins, and N. J. Besansky. 2005. Centromere-proximal differentiation and speciation in Anopheles gambiae. Proc. Natl. Acad. Sci. USA 102:15930-15935.
182. Su, X.-Z., L. A. Kirkman, H. Fujioka, and T. E. Wellems. 1997. Complex polymorphisms in an 330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell 91:593-603.
183. Su, X.-Z., M. T. Ferdig, Y. Huang, C. Q. Huynh, A. Liu, J. You, J. C. Wootton, and T. E. Wellems. 1999. A genetic map and recombination parameters of the human malaria parasite P. falciparum. Science 286:1351-1353.
184. Swan, H., L. Sloan, A. Muyombwe, P. Chavalitshewinkoon-Petmitr, S. Krudsood, W. Leowattana, P. Wilairatana, S. Looareesuwan, and J. Rosenblatt. 2005. Evaluation of a real-time polymerase chain reaction assay for the diagnosis of malaria in patients from Thailand. Am. J. Trop. Med. Hyg. 73:850-854.
185. Talisuna, A. O., A. Nalunkuma-Kazibwe, P. Langi, T. K. Mutabingwa, W. W. Watkins, E. Van Marck, T. G. Egwang, and U. D'Alessandro. 2004. Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria. Infect. Genet. Evol. 4:321-327.
186. Taylor, R. R., S. J. Allen, B. M. Greenwood, and E. M. Riley. 1998. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am. J. Trop. Med. Hyg. 58:406-413.
187. Thaithong, S., G. H. Beale, B. Fenton, J. McBride, V. Rosario, A. Walker, and D. Walliker. 1984. Clonal diversity in a single isolate of the malaria parasite Plasmodium falciparum. Trans. R. Soc. Trop. Med. Hyg. 78:242-245.
188. Triglia, T., M. T., Duraisingh, R. T. Good, and A. F. Cowman. 2005. Reticulocyte-binding protein homologue 1 is required for sialic acid-dependent invasion into human erythrocytes by Plasmodium falciparum. Mol. Microbiol. 55:162-174.
189. Trimnell, A. R., S. M. Kraemer, S. Mukherjee, D. J. Phippard, J. H. Janes, E. Flamoe, X. Z. Su, P. Awadalla, and J. D. Smith. 2006. Global genetic diversity and evolution of var genes associated with placental and severe childhood malaria. Mol. Biochem. Parasitol. 148:169-180.
190. Tuikue Ndam, N. G., A. Salanti, G. Bertin, M. Dahlback, N. Fievet, L. Turner, A. Gaye, T. Theander, and P. Deloron. 2005. High level of var2csa transcription by Plasmodium falciparum isolated from the placenta. J. Infect. Dis. 192:331-335.
191. Uhlemann, A. C., M. Ramharter, B. Lell, P. G. Kremsner, and S. Krishna. 2005. Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon. J. Infect. Dis. 192:1830-1835.
192. van Dijk, M. R., B. Douradinha, B. Franke-Fayard, V. Heussler, M. W. van Dooren, B. van Schaijk, G. J. van Gemert, R. W. Sauerwein, M. M. Mota, A. P. Waters, and C. J. Janse. 2005. Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. Proc. Natl. Acad. Sci. USA 102:12194-12199.
193. Viebig, N. K., B. Gamain, C. Scheidig, C. Lepolard, J. Przyborski, M. Lanzer, J. Gysin, and A. Scherf. 2005. A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A. EMBO Rep. 6:775-781.
194. Volkman, S. K., D. L. Hartl, D. F. Wirth, K. M. Nielsen, M. Choi, S. Batalov, Y. Zhou, D. Plouffe, K. G. Le Roch, R. Abagyan, and E. A. Winzeler. 2002. Excess polymorphisms in genes for membrane proteins in Plasmodium falciparum. Science 298:216-218.
195. von Seidlein, L., S. Jaffar, M. Pinder, M. Haywood, G. Snounou, B. Gemperli, I. Gathmann, C. Royce, and B. Greenwood. 1997. Treatment of African children with uncomplicated falciparum malaria with a new anti-malarial drug, CGP 56697. J. Infect. Dis. 176:1113-1116.
196. Watkins, W. M., C. H. Sibley, and I. M. Hastings. 2005. The search for effective and sustainable treatments for Plasmodium falciparum malaria in Africa: a model of the selection of resistance by antifolate drugs and their combinations. Am. J. Trop. Med. Hyg. 72:163-173.
197. Wernsdorfer, W. H., and H. Noedl. 2003. Molecular markers for drug resistance in malaria: use in treatment, diagnosis and epidemiology. Curr. Opin. Infect. Dis. 16:553-558.
198. Wichmann, O., N. Muehlberger, T. Jelinek, M. Alifrangis, G. Peyerl-Hoffmann, M. Muhlen, M. P. Grobusch, J. Gascon, A. Matteelli, H. Laferl, Z. Bisoffi, S. Ehrhardt, J. Cuadros, C. Hatz, I. Gjorup, P. McWhinney, J. Beran, S. da Cunha, M. Schulze, H. Kollaritsch, P. Kern, G. Fry, and J. Richter. 2004. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe. J. Infect. Dis. 190:1541-1546.
199. Win, T. T., A. Jalloh, I. S. Tantular, T. Tsuboi, M. U. Ferreira, M. Kimura, and F. Kawamoto. 2004. Molecular analysis of Plasmodium ovale variants. Emerg. Infect. Dis. 10:1235-1240.
200. Wootton, J. C., X. Feng, M. T. Ferdig, R. A. Cooper, J. Mu, D. I. Baruch, A. J. Magill, and X.-Z. Su. 2002. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418:320-323.
201. Zwetyenga, J., C. Regier, A. Tall, D. Fontenille, G. Snounou, J. F. Trape, and O. Mercereau-Puijalon. 1998. No influence of age on infection complexity and allelic distribution in Plasmodium falciparum infections in Ndiop, a Senegalese village with seasonal, mesoendemic malaria. Am. J. Trop. Med. Hyg. 59:726-735.